These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26797639)

  • 21. Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI.
    Jarvis C; Han Z; Kalas V; Klein R; Pinkner JS; Ford B; Binkley J; Cusumano CK; Cusumano Z; Mydock-McGrane L; Hultgren SJ; Janetka JW
    ChemMedChem; 2016 Feb; 11(4):367-73. PubMed ID: 26812660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens.
    Asadi Karam MR; Habibi M; Bouzari S
    Biologicals; 2016 Sep; 44(5):378-86. PubMed ID: 27461240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A flow cytometry-based assay for screening FimH antagonists.
    Scharenberg M; Abgottspon D; Cicek E; Jiang X; Schwardt O; Rabbani S; Ernst B
    Assay Drug Dev Technol; 2011 Oct; 9(5):455-64. PubMed ID: 21675870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
    Habibi M; Asadi Karam MR; Bouzari S
    Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uropathogenic Escherichia coli strains harboring tosA gene were associated to high virulence genes and a multidrug-resistant profile.
    Xicohtencatl-Cortes J; Cruz-Córdova A; Cázares-Domínguez V; Escalona-Venegas G; Zavala-Vega S; Arellano-Galindo J; Romo-Castillo M; Hernández-Castro R; Ochoa SA; Luna-Pineda VM
    Microb Pathog; 2019 Sep; 134():103593. PubMed ID: 31195111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subinhibitory Concentrations of Allicin Decrease Uropathogenic Escherichia coli (UPEC) Biofilm Formation, Adhesion Ability, and Swimming Motility.
    Yang X; Sha K; Xu G; Tian H; Wang X; Chen S; Wang Y; Li J; Chen J; Huang N
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytochemicals As Uropathognic Escherichia Coli FimH Antagonist: In Vitro And In Silico Approach.
    Jaiswal SK; Sharma NK; Bharti SK; Krishnan S; Kumar A; Prakash O; Kumar P; Kumar A; Gupta AK
    Curr Mol Med; 2018; 18(9):640-653. PubMed ID: 30608041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs).
    Tartof SY; Solberg OD; Riley LW
    J Med Microbiol; 2007 Oct; 56(Pt 10):1363-1369. PubMed ID: 17893175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple antibiotic resistances and virulence markers of uropathogenic Escherichia coli from Mexico.
    Paniagua-Contreras GL; Monroy-Pérez E; Bautista A; Reyes R; Vicente A; Vaca-Paniagua F; Díaz CE; Martínez S; Domínguez P; García LR; Uribe-García A; Vaca S
    Pathog Glob Health; 2018 Dec; 112(8):415-420. PubMed ID: 30433859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.
    Lo Y; Zhang L; Foxman B; Zöllner S
    Infect Genet Evol; 2015 Aug; 34():244-50. PubMed ID: 26112070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maturation of intracellular Escherichia coli communities requires SurA.
    Justice SS; Lauer SR; Hultgren SJ; Hunstad DA
    Infect Immun; 2006 Aug; 74(8):4793-800. PubMed ID: 16861667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients.
    Ghosh A; Mukherjee M
    Folia Microbiol (Praha); 2019 Jul; 64(4):587-600. PubMed ID: 30835050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Cranberry Extract on Tamm-Horsfall Protein in Human Urine and its Antiadhesive Activity Against Uropathogenic Escherichia coli.
    Scharf B; Sendker J; Dobrindt U; Hensel A
    Planta Med; 2019 Jan; 85(2):126-138. PubMed ID: 30312973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Distribution of phylogenetic groups and virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli strains isolated from patients in the community of Mérida, Venezuela].
    Millán Y; Hernández E; Millán B; Araque M
    Rev Argent Microbiol; 2014; 46(3):175-81. PubMed ID: 25444124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?
    Eris D; Preston RC; Scharenberg M; Hulliger F; Abgottspon D; Pang L; Jiang X; Schwardt O; Ernst B
    Chembiochem; 2016 Jun; 17(11):1012-20. PubMed ID: 26991759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli.
    Sokurenko EV; Feldgarden M; Trintchina E; Weissman SJ; Avagyan S; Chattopadhyay S; Johnson JR; Dykhuizen DE
    Mol Biol Evol; 2004 Jul; 21(7):1373-83. PubMed ID: 15044596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of mammalian codon usage of fimH in DNA vaccine design.
    Bagherpour G; Fooladi AA; Mehrabadi JF; Nourani MR; Einollahi B
    Acta Microbiol Immunol Hung; 2011 Dec; 58(4):259-71. PubMed ID: 22207284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infections.
    Habibi M; Asadi Karam MR; Bouzari S
    Adv Biomed Res; 2015; 4():217. PubMed ID: 26605246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.